On Aug. 25, 2021, Johnson & Johnson announced data supporting the use of its COVID-19 vaccine as a booster
shot for people previously vaccinated with the single-shot Johnson & Johnson vaccine.

Data from new studies demonstrated that a booster dose of the Johnson & Johnson COVID-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.